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3Dbioprinting is a technology that combines computing science, biology andmaterial engineering. It has beenex-
tensively explored to fabricate 3D vascularized constructs for tissue engineering. This scalable, reproducible and
highly precise fabrication technology offers great potential to achieve vascularization in printed tissues, which
is an important milestone towards organ printing in the foreseeable future. A successful vascularized tissue inte-
grates a range of hierarchical, perfusable channels within the mechanically supportive biomaterials. This review
summarises the recent advances in the 3D bioprinting of vascularized tissues. Firstly, the common biomaterials
usedasbioinks for 3Dbioprinting are introduced.Whilenatural polymers aremore suitable tomimic extracellular
matrix resulting in effective cell growth, synthetic polymers offer tailorablemechanical properties and printabil-
ity. Afterwards, the main 3D bioprinting techniques and their most recent practical applications in fabricating
perfusable vascular networks are described. Furthermore, the future trends and prospects are also discussed.
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
3D printing was firstly introduced by Charles Hull in 1983 [1]. With
the assistance of digital 3D computer aided design (CAD), the pre-
designed 3D structures at the desired scale can be precisely fabricated
in a bottom-up and layer-by-layer manner. As 3D printing offers great
geometric accuracy, it has found extensive applications in the fabrica-
tion of 3D structures with complex internal architecture and unique
external features without employing excessive tooling which can
incur high manufacturing costs, wastage of valuable time and ineffi-
ciency of human resources. These applications include a wide range of
areas such as aerospace engineering [2,3], automotive industries [4,5],
electronics manufacturing [6–8], tissue engineering [9–18], regenera-
tive medicine [19–21], food industries [22–24], drug delivery [25–28],
cancer research [29–33], high-throughput screening tests [34–36],
self-propelled microdevices [37–39], joint replacement implants
[40–42], prosthetics [43,44] and bio-robot models [45].
3D bioprinting is the process that patterns and assembles living and
non-living biomaterials via a 3D structural organization using com-
puter-aided transfer processes [46–48]. Because of its superior precision,
fast production and easy manipulation, bioprinting has been intensively
explored for fabricating cell-laden tissue scaffolds for tissue engineering
with the ultimate goal of organ printing [49–57]. Traditionally, the re-
placement of defected tissues/organs relies on transfer of the autologous
andallogeneic ones.However, theextreme lackof donors is themain lim-
itation which delays the effective treatment for patients [58]. To address
this issue, bioprinted tissues/organs with tissue-specific cells and cus-
tomized sizes can be the promising substitutes for the autologous/alloge-
neic treatment [59]. The advantage of using 3D bioprinting to fabricate
tissues/organs is theflexibility of usingdifferentbiomaterials and specific
cells and, thus, a multi-scale and multi-material fabrication process can
be achieved [60]. By simultaneously printing biocompatible materials as
matrices, tissue-specific cells and bioactive growth factors, following a
predesigned order of different layers, the printed 3D constructs can pro-
mote tissue regeneration and restore their functions effectively [61–63].
Natural vascular tissues/organs have a range of vessel networkswith
different structures and size range frommicrometre-sized capillaries to
millimetre-sized vessels [64,65]. Capillaries have a monolayer of endo-
thelial cells (ECs) while larger vessels have three layers: (1) an inner
EC layer; (2) a middle layer which is composed of smooth muscle cells
(SMCs), elastic tissue and collagen fibres; (3) an outer layer which is
composed of elastic tissue and collagen fibres [66]. Moreover, different
sized vessels have different types of ECs, and the following three types
of ECs are commonly used in tissue engineering applications: human
umbilical vein endothelial cells (HUVECs), human microvascular endo-
thelial cells (HMVECs), and induced pluripotent stem cell-derived
endothelial cells (iPSC-ECs) [66]. Amongst them, HUVECs are the most
frequently used endothelial cell type for bioprinting vessels. HMVECs
have great potential to form microvascular networks as they are origi-
nally obtained from micro-vessels. As iPSCs are capable of self-
renewal and multi-lineage differentiation, ECs derived from iPSCs are
an ideal autologous alternative to primary ECs [67]. Additionally, as
human iPSCs (hiPSCs) reprogrammed from patients’ specific cells do
not cause immunological response, the hiPSC-ECs have gained exten-
sive attention for 3D bioprinting of customized vascularized tissues/or-
gans [68–70]. On the other hand, SMCs play an important role in vessel
structure and function in physiological and pathological conditions.
In terms of vessel formation, vasculogenesis and angiogenesis are
the two most studied models. Vasculogenesis triggers the formation of
primitive vascular plexus during embryonic development. It also hap-
pens in the process of EC differentiation from endothelial progenitor
cells. Angiogenesis is the process in which ECs sprout and form new
blood vessels from pre-existing vessels. It normally has two stages:
sprouting and intussusception. Sprouting needs the assistance of
growth factors such as vascular endothelial growth factor (VEGF),
angiopoietin-2 (Ang2), and fibroblast growth factor (FGF) to trigger
the proangiogenic gene in quiescent vessels to form interstitial col-
umns/tubes. Intussusception is the process in which the interstitial cel-
lular columns are inserted into the pre-existing vessels followed by the
growth of those columns to form new vessels [66].
Although current 3D bioprinting has achieved a remarkable break-
through in fabricating a small range of vascular networks in vitro,
there is still a gap between clinically implantable vascularized tissues/
organs and the capabilities of the current techniques. One of the vital
challenges of 3D bioprinting of vascularized tissues is to create a range
of hierarchical and perfusable channels with specifically allocated bio-
materials and cells to allow the access of cells to nutrients and oxygen,
and removal of wastes [71–75]. Lack of suitable vasculature in the
bioprinted tissues has limited its applications in the area of tissue regen-
eration [76,77]. Manufacturing of personalised tissues/organs would be
the ultimate goal of 3D bioprinting, as patients can be treated more ef-
ficiently and effectively by transplanting customised tissues/organs in-
stead of the allogeneic ones [78]. Overall, a successful 3D bioprinted
tissue should have the following typical characteristics: (1) replicate
the tissue-specific vascular networks in a certain size range; (2) possess
sufficient mechanical properties which match the host tissue; (3) inte-
gratewith the body vascularization system tomaintain tissue functions.
This review summarises the recent advances in the 3Dbioprinting of
vascularized tissues. The commonly used biomaterials, 3D bioprinting
techniques and their most recent practical applications in fabricating
perfusable channels/vascularized constructs are described. Further-
more, the future trends and prospects are also discussed.
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2. Biomaterials used in vascular bioprinting
Biomaterials and cells are the most important components used in
vascular bioprinting. It has recently been defined by Groll et al. [79]
that a 'bioink' is a formulation of cells that may also contain biologically
active components and biomaterials and is suitable for processing by an
automated biofabrication technology. On the other hand, a formulation
containing only biomaterials and/or bioactive components was defined
as 'biomaterial inks' [79]. The ideal biomaterials used in bioinks or
biomaterial inks for fabricating vascularized tissue should not only be
capable of forming 3D structures with high resolution, appropriate me-
chanical properties and biodegradability to act as a supportive frame,
but also possess good biocompatibility and low cytotoxicity to facilitate
cell growth. Natural polymers such as fibrin, collagen, gelatin and algi-
nate possess excellent biocompatibility which allows them to be com-
monly formulated with cells to form bioinks. Besides, they are suitable
to mimic extracellular matrix (ECM) environment, leading to effective
cellular growth and function, hence resulting in effective tissue regener-
ation. However, these biomaterials usually encapsulate and confine
cells, which results in limited cell-to-cell interactions [80]. Furthermore,
natural polymers commonly have poor mechanical properties and un-
desirable fast degradation rates which limit their applications in
bioprinting. Therefore, synthetic polymers have been increasingly
used or combined with natural biomaterials to print 3D constructs for
tissue engineering as they can offer excellent mechanical property to
match the loading requirements of native tissues or organs. Moreover,
synthetic polymers have tailorable processability which is beneficial to
the resolution of 3D bioprinting [81]. Therefore, composite materials
composed of both synthetic polymers and natural biomaterials are the
best promising candidates for 3D bioprinting in the future.
2.1. Natural polymers
2.1.1. Collagen
Collagen is themain component of ECMwhichmakes it an excellent
candidate for supporting cell growth for tissue regeneration. Type I col-
lagen hydrogels are the most frequently used collagen protein type for
3D printing of vascularized tissues as they provide an ideal microenvi-
ronment for angiogenesis. In order to facilitate the formation of specific
vasculature, the concentration of collagen needs to be carefully selected.
Collagen gels with concentrations between 1.2 to 1.9 mg/mL support
stable sprout formation as they allow the EC proliferation andmigration
[82]. Collagen has been primarily used for extrusion-based bioprinting
as it offers quick gelation rate under suitable conditions and acceptable
mechanical properties after gelation. The gelation kinetics of collagen
hydrogels are dependent on pH and temperature, with a maximum
storagemodulus recorded at pH8 and 37 °C, respectively [83]. However,
lack of sufficient mechanical properties is the main limitation of apply-
ing collagen-only hydrogels as load-bearing tissue scaffolds [84]. There-
fore, synthetic polymers with better mechanical properties were
combined with collagen to support the structure of the final constructs.
In order to improve the printability of collagen gels, biocompatible
and non-toxic crosslinkers, such as tannic acid, can be adopted [85].
With the assistance of crosslinker, a 3D structure of intestinal villi
with an endogenous capillary network has been reported recently
[86]. In addition to a suitable crosslinker, materials with relatively fast
gelation rate can be blended with collagen to optimise the printability
of collagen hydrogels. Alginate has been used for blendingwith collagen
to accelerate the gelation process and achieve a better shape fidelity.
After gelation, alginate was removed from the structure by chelation,
leaving a collagen-only 3D structure. Although collagen has been prom-
isingly used for 3D bioprinting, its inferior printability hinders its appli-
cation for printing vessels with high resolution. Other than blending
with different materials to improve the printing resolution of
collagen-based hydrogels, using suitable printing techniques may be
another solution to address this issue.
2.1.2. Gelatin
Gelatin is a fibrous protein derived from collagen by irreversible
hydrolysis. Gelatin has the advantages of high water-absorbing ability,
excellent biocompatibility, non-immunogenicity and complete biode-
gradability. Aqueous gelatin is thermosensitive and forms hydrogel
through hydrogen bonding at low temperatures (< 35 °C), whereas at
37 °C, the solid gelatin can turn into viscous liquid and easily be printed
using extrusion-based printing. As pure gelatin dissolves completely
within 24 hrs, it is usually used as a sacrificial support material which
is removed after printing, leaving hollow channels for obtaining
vascularized tissues. As mentioned above, as HUVECs are the main en-
dothelial cell type used to form vessels. HUVEC-laden sacrificial gelatin
bioink has been increasingly used to fabricate vascularized tissues.
After removing gelatin from the matrix, which is usually collagen, the
inner surfaces of the hollowed channels get lined with HUVECs which
promote the vessel formation by angiogenesis. Although researchers
have endeavoured to improve the printability and stability of gelatin-
based bioinks, for example, by using thickeners (e.g. nanoclay) and
transglutaminase to increase the shape fidelity of final gelatin 3D struc-
tures [87,88], low printing resolution (> 100 μm) is themain obstacle in
using gelatin-based bioinks as matrix materials for 3D bioprinting.
To address this issue, gelatin has been methacrylated which can be
covalently cross-linked to forma strongermaterial (i.e. GelMA)with de-
cent biological and physicochemical properties for 3D bioprinting.
GelMA has excellent processability and can be reversibly crosslinked
byheat and irreversibly stabilized byUV [89,90].Moreover, thephysico-
chemical properties of final products can be tuned by crosslinking den-
sity of methacryloyl group. Therefore, GelMA is a promising biomaterial
that can preserve the integrity of the final bioprinted constructs and
maintain a good cell viability, proliferation and spreading for 3D
bioprinting of vasculature [91]. In order to directly print perfusable
channels, GelMA has been increasingly combined with alginate for co-
axial extrusion-based printing.With the assistance of rapid-gelling algi-
nate, the shape fidelity of the coaxially printed tube can be well
preserved. Again, ECs, such as HUVECs, and growth factors, such as
VEGF, can be blended into those bioinks to form vessels in the final
structures with good cell viability. Additionally, the mechanical prop-
erties of GelMA-based hydrogels can be tuned according to the req-
uirement of specific tissues. Soft GelMA-based hydrogels promote
vasculogenesis and capillary formation of human dermal microvascular
ECs, while stiffer GelMA-based hydrogels support osteogenesis and
bone formation. Themain disadvantage of usingGelMA asmatrixmate-
rial for bioprinting is the UV-dependent gelation process. UV exposure
and toxic photoinitiators have been reported that negatively affect
cell-viability. Therefore, crosslinking using blue light (405 nm) is more
preferred.
2.1.3. Decellularized extracellular matrix
Decellularized extracellular matrix (dECM) is the cell-removed tis-
sue which retains the ECM frameworks. As ECM is amixture of different
components, such as collagen, elastin and growth factors, dECM is a cell-
friendlymaterialwhich offers excellent biological activity, easy process-
ability and tailorable degradation rates [92,93]. These advantages make
dECM a promising candidate for 3D bioprinting of vascularized tissues
without an excessive number of steps for blending different ingredients.
Moreover, as each tissue or organ has its specific ECM components,
using dECM of targeted tissue offers better cellular growth and function
than using other biomaterials [94]. Additionally, tomatch the stiffnesses
of different tissues, the mechanical properties of printed dECM constr-
ucts can be tailored by incorporating crosslinkers such as PEG-based
crosslinkers or methacrylating dECM to make it UV-crosslinkable
[95,96]. As the components of different tissues support different biolog-
ical functions, it is ideal to use dECMwhich is derived from natural vas-
cular tissues, such as ethically derived aorta and venae cavae, as the
biomaterial for bioprinting of vascularized tissues. Furthermore, consid-
ering the potential immune response and accidental pathogen transfer
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induced from the non-autologous dECM, it is ideal to use patient-
specific tissue derived dECM as the biomaterial for printing vascularized
tissues [97,98].
However, a relatively slow gelation process hinders the use of dECM
for 3D bioprinting as the shape fidelity is poorly preserved. This disad-
vantage can be improved by incorporating fast-gelling materials such
as alginate. Furthermore, making dECM UV-crosslinkable provides the
potential to use laser-assisted printing techniques to increase the print-
ing resolution of the final 3D structures.
2.1.4. Fibrin
Fibrin is the main extracellular constituent of blood clot and pos-
sesses inherent cell-adhesion capabilities on account of its multiple
cell-adhering motifs [99,100]. Fibrin helps EC proliferation by directing
associated cells to growth factors, such as VEGF and FGF, to promote an-
giogenesis [101,102]. Fibrin also supports the growth of ECs as a scaf-
folding material and exhibits shear-stiffening property under high
strains, which canmimic the non-linear elastic behaviour of soft tissues.
Therefore, fibrin has been widely used for wound healing and tissue
remodelling [103–105].
However, lack of decentmechanical property and rapid degradation
are the main limitations of using fibrin as a 3D bioprinting material.
Therefore, blending fibrin with more printable polymers to make me-
chanical property and degradability more tunable could be a solution
to address this issue. Another possible option is to chemically modify fi-
brin, for example, by conjugating fibrin with PEG to better control the
mechanical properties while maintaining good bioactivity of fibrin.
2.1.5. Alginate
Alginate, which is renewably sourced from brown algae, forms hy-
drogel through ionic crosslinking in the presence of divalent cations,
such as Ca2+, Mg2+ and Ba2+. The cross-linked alginate hydrogel is
composed of hydrophilic polymer chains which have a large water-
holding capacity. Moreover, its porous internal structure plays an
important role in the diffusion of nutrients and gases for cellularmetab-
olism and removal of the resultant wastes. Therefore, alginate hydrogel
has been widely used as scaffolding material for tissue engineering. As
alginate possesses rapid gelation capability, which improves the shape
fidelity, tailored degradability and shear-thinning characteristic which
minimises the effect of shear stress on cells, it has been extensively
used in inkjet and extrusion-based 3D bioprinting [91,106]. For inkjet
printing, the viscosity of inks is mainly affected by concentration and
molecular weight of alginate, cell density and temperature, with too
viscous inks (> 20 mPa s) being not able to be jetted out [107]. Pre-
crosslinking is usually applied before extrusion-based printing to
provide sufficient deposition quality followed by exposing the printed
scaffolds to high concentration crosslinker to achieve full crosslinking.
In addition to being a matrix material, alginate has also been used as a
sacrificial material to help achieve a high shape fidelity in perfusable tu-
bular structures [108]. The removal of the ionically cross-linked alginate
hydrogels from a construct can be achieved by releasing the divalent
ions crosslinkers via exchange reactions with monovalent cations pres-
ent in the surrounding medium [109].
Although ECs have been incorporated with alginate to form bioinks
for 3D bioprinting of vascularized tissues, the viability of ECs in alginate
hydrogels was only around 71% with alginate hydrogels not supporting
vascular morphogenesis, which is not ideal compared to that of other
aforementioned biomaterials [110]. In order to improve its biocompati-
bility and bioactivity, incorporating more cell-friendly biomaterials,
such as collagen and fibrin, and/or proangiogenic growth factors, such
as VEGF, have been approved as good approaches to facilitate the vascu-
lar network formation [111]. Furthermore, as alginate does not have
RGD molecules, which are responsible for cell attachment, synthetic
peptideswith RGDmolecules are incorporatedwith alginate to improve
cell growth [112].
2.2. Synthetic polymers
Synthetic polymers, such as poly(ethylene glycol) diacrylate
(PEGDA), and poly(ethylene glycol)-tetra-acrylate (PEGTA), have been
used for 3D bioprinting of vascularized constructs on account of their
tailorable mechanical properties, processability and biocompatibility.
PEGDA and PEGTA are PEG derived photocrosslinkable polymers
which contain acrylate groups for photopolymerization. Therefore,
PEGDA and PEGTA are commonly used for UV/visible light assisted
printing techniques. The crosslinking rate of these two polymers ranges
from several seconds to minutes depending on the type and concentra-
tion of photoinitiators [113]. The printability is affected by rheological
propertieswhich are dependant onmolecularweight and concentration
of polymers. As PEG itself is not an ideal material for cell growth due to
the lack of cell-adheringmoieties, PEGDA and PEGTA are normally com-
bined with other cell-friendly materials such as GelMA to improve their
cell response. PEGDAacts as a better scaffold for cell growth and spread-
ing due to its branched tetravalentmolecular structure andmultiple ac-
tive crosslinking sites which allow formation of more porous and stiffer
structures [114,115].
Pluronic® is another frequently used synthetic polymer for 3D
bioprinting of vascular networks. It is a polyoxyethylene–polyo-
xypropylene–polyoxyethylene (PEO–PPO–PEO) amphiphilic triblock
copolymer which possesses thermoreversible gelation behaviour. Be-
cause of this characteristic, Pluronic® is usually used as a sacrificial bio-
material which can be removed leaving behind patterned vascular
networks. By incorporating ECs and cell-friendly biomaterials such as
GelMA, fibrin and collagen, vascular networks (5-500 μm) with an-
giogenic sprouting can be obtained [116–118]. However, the main
disadvantage of using Pluronic® is the need for a low temperature
(< 4oC) to liquefy this polymer, which limits its application in other
high-resolution printing techniques other than extrusion. Therefore,
capillary-scale networks cannot be bioprinted by using Pluronic®.
3. Bioprinting techniques
3.1. Inkjet bioprinting
While inkjet printers have been ubiquitously used in offices and
homes to print 2D texts and images on paper, researchers are more in-
terested in exploring further potential functionalities of such printers to
fabricate 3D biological constructs which require a precise deposition of
biomaterials as droplets and high-resolution patterning on a specific
substrate. Inkjet printing can work either with a single-ink system or a
multiple-ink system, both approaches can precisely print single/multi-
ple materials at micrometre resolution with essentially no restrictions
on the geometric complexity of the spatial arrangement. Therefore,
this technique has the potential to create constructs or cell scaffolds
with complex internal structures, such as connected channels and
pores, which are of great importance for cell growth. There are two
main types of inkjet printing: (1) Continuous inkjet printing (CIJ) and
(2) Drop-on-demand inkjet printing (DOD). However, CIJ has a few crit-
ical limitations, such as the risk of contamination of final products, the
obligatory use of electrically conductive inks and low printing resolu-
tion. Therefore, DOD is the most common inkjet printing technique
which has been extensively used for 3D bioprinting.
DOD inkjet printing generates droplets only at required places by
propagating a pressure pulse in a fluid filled chamber. Because droplets
are only ejected when required, the material waste is minimal com-
pared to CIJ. DOD inkjet printing also minimises the risk of contamina-
tion of product because a recycling system is not needed, which
means the ink used is always fresh. DOD inkjet printing can be further
divided into two sub-types as shown in Fig. 1: (1) piezoelectric DOD
inkjet printing, in which the formation of droplets occurs bymechanical
actuation of a piezoelectric material which surrounds the ink chamber,
this sudden volume change of the ink chamber generates droplets.
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(2) Thermal DOD inkjet printing, in which a vapour bubble is generated
by a heater/resistor which can vaporise a small volume of the ink caus-
ing a droplet to be ejected.
As mentioned earlier, different materials can be printed through in-
dividual channels using DOD inkjet printing, which allows for reactive
inkjet printing, in which a droplet of one ink can be accurately printed
on top of a deposited droplet of another ink, causing reactions and for-
mation of product material at the specified positions [119]. Reactive
inkjet printing is usually used to print materials which are insoluble or
barely soluble to form printable liquid inks but can be formed through
reaction with different liquid reactant materials. This approach opens
a new window for printing materials and solidification mechanisms,
thus facilitating formation of 3D constructs with tricky outer and inner
structures.
Inkjet printing has been successfully used to print cell-laden mate-
rials with high post-printing cell viability which is the first step towards
bioprinted 3Dvascularized tissues [121,122]. As vascular networks have
complex branches, one of the challenges is to print overhanging
structures, especially without a supporting material. Improving the
quality of overhanging structures and fully addressing this challenge is
essential to the success of fabricating vascular networks. After the first
successful tubular structure fabricated by inkjet printing in 2009 [123],
Christensen et al. [120] reported that two vessel-like tubular structures
with bifurcations were fabricated using reactive inkjet printing with
alginate hydrogel. Fig. 2(a, b) schematically illustrates two setup config-
urations, in horizontal and vertical directions, for printingwhich can ad-
dress the challenge of non-printability of overhanging structures. Fig. 2
(c-h) shows different views of inkjet-printed alginate tubular structures
with or without cells. It was noticed that structures printed without
cells had higher feature resolution than those printed with cells. This
difference in resolution was due to the presence of cells in the bioink
causing a poor quality of droplet formation andwider deposition trajec-
tories during printing. The cell viability was tested to investigate the ef-
fect of the printing process on the living cells (NIH 3T3 mouse
fibroblasts). It was found that the viability of the cell within the post-
printed structure was 92.4% right after printing and 90.8% after 24
hours of incubation, indicating negligible effect of the printing process
on the viability of the printed cells. However, the perfusion performance
under long-term cell culture environment is missing in this early re-
search. Another limitation is that this work did not integrate the
bioprinted tubular structures with the parenchymal tissue for fabricat-
ing a functional vascularized tissue model as the 3D structures were
printed directly into a crosslinker pool which did not have necessary
constituents for cell culture and growth.
The main advantages of using inkjet printing as a 3D bioprinting
strategy are: (1) using as low as pico-litre volume of materials which
can dramatically save the costs of biomaterials, such as growth factors,
hormones and enzymes, which are very expensive [124]; (2) precise
control of deposition of droplets allowing a high, micrometre scale res-
olution [125]; (3) the non-contact characteristic of inkjet printing min-
imises the risk of cross-contamination of the final product, and the
waste of material is minimised; (4) it is easy to introduce gradients in
concentration or number of biomaterials or cells by altering the droplet
size and frequency [126]. However, it also has intrinsic drawbacks:
(1) limited choices of printable materials due to the specific require-
ments of viscosity and surface tension; (2) the mechanical stress and
heat during jetting process may affect the activity of cells and sensitive
biomaterials [124]; (3) the nozzle geometry may affect printing pat-
terns at high resolution [125]; (4) clogging of the nozzle leading to ir-
regular droplet sizes and directionality [124]; (5) difficulty in
achieving large scale constructs due to the slow fabrication speeds of
droplet-based printing; (6) cell aggregation and sedimentation in ink
reservoir. However, inkjet printing offers the potential to fabricate
multi-material and multi-scale constructs with complex vascular struc-
tures at a high printing resolution, as its building block, i.e. jetted drop-
let, has a very small volume in picolitre range [127].
Fig. 1. Schematic illustrations of drop-on-demand (DOD) piezoelectric and thermal inkjet
printing.
Fig. 2. (a, b) A schematic showing the inkjet printing systemand the processwith different printing directions. (c, d) Top and global viewof a bifurcated structure using horizontal printing
(without cells). (e, f) Top and global view of a bifurcated structure using vertical printing (without cells). (g, h) Global view of inkjet-printed structure with both horizontal and vertical
bifurcations with (g) and without (h) cells. Scale bar, 3 mm. (images adapted from ref. [120] Copyright © 2014 Wiley-VCH)
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3.2. Extrusion-based bioprinting
In the extrusion-based bioprinting, (bio)inks are dispensed by a
deposition system which allows the precise deposition in the form of
cylindrical filaments. The deposited (bio)inks require suitable solidifica-
tionmechanisms to achieve good stability after printing. The key advan-
tage of extrusion-based bioprinting is the high printing speed which
allows large scalability in a short period of time. Additionally,
extrusion-based bioprinting is also capable of printing cell-laden mate-
rials with high cell density which is essential for any potent post-
biofabricated tissues/organs [128–131]. However, extrusion-based
bioprinting also has its intrinsic drawbacks: (1) the resolution is nor-
mally low. Typically, the minimum size of final product is over 100 μm
[132], resulting in the lack of precise patterning and organizing of
cells; (2) the materials used in extrusion-based printing require the
shear thinning ability to overcome their surface tension to ensure
proper extrusion in the form of cylindrical filaments; (3) for cell-laden
bioinks, the shear stress or the solidification methods may harm the
viability of living cells.
3.2.1. Mechanical extrusion bioprinting
The bioinks used formechanical extrusion-based bioprinting are for-
mulated in semi-liquid or hydrogel form. The bioinks are then pushed
out through a nozzle using either pneumatic pressure or a piston or a
constantly forward-rotating screw inside the ink reservoir. Fig. 3(a) il-
lustrates the pressure-driven and screw-driven extrusion printing. The
piston-driven extrusion provides faster and better controllability over
ink deposition in comparison to the pneumatic extrusion where the
changes made in the gas volume takes longer time to show effect on
the ink dispensing. Screw-driven extrusion are better suited for very
high viscosity hydrogels. They are, however, less suitable for cell-laden
hydrogels as the relatively higher pressure and shear stress may nega-
tively affect the viability of the embedded cells. The rate of extrusion de-
pends on the required geometric complexity and resolution of the
construct being fabricated and on the physiochemical properties of
the (bio)inks such as the solidification time and tolerance to shear
stress. Tomaintain a self-standing structure, inks with higher viscosities
than those used in droplet-based printing are used [133].
3.2.2. Thermal extrusion bioprinting
Fused deposition modelling (FDM) is a variant of extrusion-based
printing. It is capable of fabricating 3D structures by depositing ther-
mally softened materials, such as thermoplastics and sugars, through a
heated nozzle as illustrated in Fig. 3(b). In FDM, solid state materials
(e.g. filament, powder, pellet) are heated to a temperature near their
specific melting point, and are then extruded out of a heated nozzle as
semi-molten strings following predefined CAD based patterns to form
layers. Once a layer is completed, the substrate/platform moves down
in Z direction by a predefined distance (layer thickness) to start printing
the next layer. Some commercial FDM machines can process multiple
materials at a time, allowingmore than onematerial to be deposited si-
multaneously, forming multi-material constructs, or using the second
material as supporting or sacrificial material which can be easily re-
moved after printing.
As aforementioned, a successfully engineered tissue/organ requires
the fabrication of vascular networks with hierarchical and perfusable
channels [134]. Currently, there are two approaches, which are direct
and indirect printing, to achieve perfusable channels. Direct printing
uses cell-laden or cell-compatible materials as (bio)inks which are re-
quired to possess relatively fast solidification rate to form a stable con-
struct. However, direct printing of hollow channels has strict
requirements in terms of materials, solidification mechanism, etc.
which narrow down the choices of printable materials and printing
methods. In order to address this challenge, the indirect printing
approach prints sacrificial mold together with other supportive bioma-
terials to fromamulti-materialmatrix system [135,136]. Once theprint-
ing process is finished, the sacrificial mold is removed to form the
hollow structures. This method has been recently explored to better
mimic native organ-specific tissues in terms of mechanical properties,
geometries and biocompatibility [98,137–139].
Coaxial extrusion printing has been increasingly explored for direct
3D bioprinting of vascular constructs on account of their simplified
printing process and scalability [140–144]. By precisely printing specific
cell-laden bioinks according to the native blood vessel structure, the
emulated vascular constructs can be achieved. Jia et al. [115] designed
a multi-layered coaxial extrusion bioprinting system and successfully
fabricated a range of cell-laden vascular constructs using a biocompati-
ble hydrogel mixture containing GelMA, alginate and PEGTA. The solid-
ification of the cell-laden hydrogel mixture was achieved by two-step
crosslinking: ionical crosslinking of alginate and photo-crosslinking of
GelMA and PEGTA as shown in Fig. 4(a). The printability of the mixture
and themechanical properties of the crosslinked construct can be tuned
by altering the ratio between GelMA and PEGTA. The size of the
vascularized constructs can be manipulated by using different designs
of multi-layered coaxial nozzles (Fig. 4(b)). As can be seen from Fig. 4
(c), vascularized constructs with different sizes were successfully fabri-
cated. Moreover, the biocompatibility of the bioprinted vascularized
constructs was validated as the embedded endothelial and stem cells
Fig. 3. Schematic illustrations of (a) mechanical extrusion, which has three main types according to the mode of operation; and (b) Fused deposition modelling (FDM).
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performed a good spreading and proliferation. Similarly, instead of
printing the ECs together with the hydrogel to form the channel wall di-
rectly, Cui et al. [145] recently used the same method to fabricate self-
standing and small-diameter vascularized constructs which is inte-
grated with the SMCs and ECs to replicate the complexity and
functionality of natural blood vessels. By coaxial printing of the inner
(endothelial cell-loaded slurry) and outer (smooth muscle cell-loaded
catechol-functionalised GelMA, GelMA/C) chambers followed by post
crosslinking, the vascularized constructs with ECs were achieved with-
out collapse as shown in Fig. 4(e-k). The authors claimed that the needle
Fig. 4.Coaxial 3D extrusion bioprinting of vascular constructs. (a) A schematic showing the bioprinting process of thehollowchannelswhichwere achievedby two-step crosslinking of the
cell-laden hydrogel mixture where alginate was crosslinked by CaCl2; GelMA and PEGTA were crosslinked by UV. (b) The designed multi-layered coaxial nozzles and schematic diagram
showing fabrication of perfusable hollow tubes with constant diameters and changeable sizes. (c) Fluorescence microscope images of the hollow channels fabricated by coaxial extrusion
printing with different sizes. (d) Fluorescence microscope image of a perfusable vasculature which was illuminated by green fluorescent beads. The inset is the enlarged image of the
perfusable hollow channels which were illuminated by red fluorescent beads. (images adapted from ref. [115] Copyright © 2016 Elsevier Ltd.) (e) A schematic showing the
vascularized construct fabricated by coaxial 3D extrusion printing. (f) Photo image of the extrusion bioprinter. (g) The side view of the bioprinted vascular construct. (h) The top view
of the vascular construct after 24h of perfusion culture. (i) Microscopic images and 3D optical maps of the bioprinted vasculature in straight and bifurcated regions. (j) SEM image of
the cross-sectional morphology of bioprinted hollow channel. (k) Enlarged SEM image of the cross-sectional surface of the bioprinted hollow channel. (images adapted from ref. [145]
Copyright © 2019 IOP Publishing Ltd.)
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(printhead) gauge can be easily replaced to fabricate vascularized con-
structs with different sizes to mimic the hierarchical vascular networks
in native tissues. In order to increase the cell affinity, which results in
improvement in generation of functional tissues, Gao et al. [146] used
vascular-tissue-specific bioinks, i.e. combinations of vascular-tissue-
derived extracellular matrix and alginate with ECs and vascular smooth
muscle cells, respectively, to fabricate vascularized constructs by using
coaxial extrusion printing. The advantage of this work over others was
the in vivo study which showed excellent patency, well-retained endo-
thelium, matured smooth muscles, and integration with host tissues.
These pioneer works showed that the coaxial extrusion printing pos-
sesses the great promise of fabricating vascular constructs with high as-
pect ratio. The flexibility of dimensions, such as diameter and length,
makes coaxial extrusion printing highly suitable for fabricating tubular
constructs. However, using coaxial extrusion printing to print branched
structures is yet to be achieved.
Although fabrication of vessel-like hollow channels has been suc-
cessfully achieved as mentioned above, printing multi-scaled heteroge-
neous constructs is still required to match the native tissues. Most
recently, Kang et al. [147] successfully fabricated a heterogeneous,
multi-cellular, and multi-material construct which was aiming to
mimic the liver unit, i.e. hepatic lobule, by using extrusion bioprinting
of alginate and gelatin. Fig. 5(a) schematically shows the setup of the
multi-scaled extrusion bioprinting. It can be seen that the fabricated he-
patic lobule was composed of ECs, hepatocytes and lumen (hollow
channel). By simultaneous printing of the three materials, a multi-
scaled and vascularized biomimetic construct was obtained (Fig. 5
(b)). Fig. 5(c) shows the well-preserved structural integrity of the con-
struct, fabricated by using the pre-set cartridge, after in vitro culture for
7 days, whereas the mix-printed sample showed inconsistencies in the
structure. This is attributed to the spatial cell arrangement and en-
hanced cellular organization of each cell type.
However, the directly printed vascular constructs without suppo-
rting materials are prone to deform or collapse when printing tissues,
especially organs with significantly larger dimensions and higher com-
plexity. Therefore, an alternative 3D extrusion printing strategy has
emergedwhichdirectly prints the large-sized constructs in a supporting
medium. Noor et al. [98] used this method to successfully print a
cellularized human heart with major blood vessels using cardiac and
endothelial cell-laden hydrogels as shown in Fig. 6. The left and right
ventricles of the printed heart were injected with red and blue dyes,
respectively, in order to demonstrate hollow chambers and the septum
in-between them as shown in Fig. 6(e). Similar method has been
recently adopted to fabricate tumor models (glioma) to evaluate the
mechanism of angiogenesis and tumor vascularization, which provides
a feasible approach for fabricating microenvironment for vascul-
arization [148].
Anothermethod to address the issues associatedwith direct printing
of vascularized constructs is indirect printing where a sacrificial mold is
used. Recently, personalized thick and vascularized cardiac tissue has
been fabricated using indirect 3D extrusion bioprinting. The bioink
contained cardiomyocytes and ECs which were differentiated from
Fig. 5. (a) Schematic illustration of the pre-set extrusion bioprinting technique for hepatic lobule printing. (b) Averagewidth of the printed construct. (c) Structural integrity inspection by
immunostaining of CD31 (red), albumin (green), MRP2 (green), and nucleus with DAPI (blue) on day 7 post-printing. (images adapted from ref. [147] Copyright © 2020 Wiley-VCH).
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patient’s reprogrammed hiPSCs. Therefore, the final printed constructs
fully match the immunological, biochemical and anatomical properties
of the patient [98]. Skylar-Scott et al. [139] also used hiPSCs and indirect
3D extrusion printing to successfully fabricate a vascularized cardiac tis-
sue. As sacrificial material was used to create hollow vascular channels
whichwere embedded in thematrix, the authors named this biomanuf-
acturing method as sacrificial writing into functional tissue (SWIFT) as
shown in Fig. 7(a). In order to investigate the effect of the vascular net-
works on the cell viability after printing, a perfusable tissue with high
cell density and vascular channels was fabricated as shown in Fig. 7(b,
left). After removing the sacrificial ink, gelatine, the vascular channels
were perfused with hyperoxygenated medium (95% O2, 5% CO2) at a
flow rate of 250 μL/min for 12 hours. It can be seen from Fig.7(b,
right) that the printed vascular channels remained as hollow channels
and cells remained viable. To demonstrate the ability of fabrication of
organ-specific tissue by using SWIFT, a cardiac structurewith an arterial
vascular network geometry was fabricated as shown in Fig. 7(c). The
most advantageous development of this work over other embedded
printing for organ-specific tissue fabrication is the long-term perfusion
test and the prolonged cell viability in vitro. This work paves the way
towards the fabrication of personalised organ-specific tissues with
high cell density and vascular networks for therapeutic applications.
Using thermal extrusion bioprinting to fabricate vascularized con-
structs was firstly introduced byMiller et al. [149] using an FDM printer
in 2012. The concept was to print a sacrificialmold (carbohydrate glass)
whichwas subsequently cast with cell-laden hydrogels such as alginate,
PEG, agarose and Matrigel. After casting, the sacrificial mold was re-
moved from the cell-laden hydrogels to create perfusable channels as
shown in Fig. 8(a, b). The author claimed that the channel networks
can be perfused within minutes and support the lining of the ECs
(Fig. 8(c)). However, it is difficult to create complex sacrificial molds
without printing support materials. In order to create complex vascular
networks, Pimentel C. et al. [150] employed Poly(lactic acid) (PLA) as
the support material to generate Poly(vinyl alcohol) (PVA) sacrificial
molds using FDM, as shown in Fig. 8(d). After printing, the Poly(lactic
acid) (PLA) was removed leaving behind the water-soluble PVA sacrifi-
cial mold (Fig. 8(e-g)). Like Miller’s work, the sacrificial mold was
subsequently cast with a cell-laden ECM followed by a thorough perfu-
sion to remove the sacrificial PVAmold. However, therewas difficulty in
creating hollow channels with diameter less than 1 mm due to the
Fig. 6. (a) Schematic illustration of 3D constructs fabricated in a supporting medium usingmechanical extrusion printing. (b) The human heart CADmodel. (c, d) A printed heart within a
supportingmaterial bath. (e) A printed heart withmajor blood vessels after crosslinking. Blue and red dyes demonstrate the hollow chambers created in the heart. (f) 3D confocal image of
the printed heart (cardoimyocytes (CMs) in pink, endothelial cells (ECs) in orange). Scale bar, 1 mm. (g) Cross-sections of the heart immunostained against sarcomeric actinin (in green).
Scale bar, 1 mm. (images adapted from ref. [98] Copyright © 2019 American Association for the Advancement of Science)
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weakness of PVA, indicating that a stronger sacrificialmaterial is needed
if creatingminute capillary networks. Additionally, the fabricated vascu-
lature cast in a soft hydrogel could maintain its structural integrity after
two weeks’ perfusion, which facilitated the long-standing in vitro bio-
logical tests. Excellent cell viability was also achieved, whichwas attrib-
uted to the good perfusability of the vascularized construct.
While extrusion-based bioprinting is capable of fabricating complex
vascular networks in the relatively large sized constructs through direct
or indirect printing, 3D vascular networks with hierarchical sized ves-
sels have not been reported yet. Furthermore, using current extrusion-
based bioprinting technique to fabricate micrometre-scale capillaries
is not feasible due to its inherent low printing resolution.
3.3. Stereolithography (SLA)
In stereolithography (SLA), photochemically reactive inks, which
can be cross-linked with infra-red, UV and high-intensity laser, are
used for fabrication of 3D structures with micron-scale resolution. In
SLA, light acts as an etching agent to remove inks from certain locations
for obtaining the desired structure on the substrates. Fig. 9(a) schemat-
ically shows the conventional SLAwhich is capable of developing tissue
scaffolds with more than one spatially distributed microenvironments
and helps in lineage differentiation when stem cells are cultured on
them with different growth factors in different microenvironments
[151]. This is an important step in the direction towards full-scale
in vitro organ printing and maturation.
Continuous liquid interface production (CLIP) is an upside-down
form of SLA, in which, the curing light is used to illuminate the resin
bath from below through a transparent window at the base of the
resin bath container as shown in Fig. 9(b). The support plate on which
the structure is fabricated is dipped into the resin bath from top. As
curing light is shown according to the 3D CAD model, the resin forms
structure on the support plate, which is continuously moved upwards
allowing fresh resin to fill the gap and the structure to grow in size
[152].
SLA has been successfully used to create vascular networks for circu-
lation of oxygen and cell growth gradients [153,155]. Cui et al. [153] re-
cently employed SLA to fabricate a 3D vascularizedmodel to investigate
the breast cancer metastasis to bone. By using a light crosslinkable ma-
terial, GelMA/PEGDA with or without nano-hydroxyapatite (nHA), the
author successfully printed a 3D vascularized construct which consists
of three chambers: micro-vascularized bone, endothelialized vessel
and cancer tumour as shown in Fig. 10(a-d). This 3D printed cancer
model provides an approach to mimic transendothelial migration and
colonization of cancer cells, which paves theway towards the screening
of novel anticancer drugs and the development of customised
Fig. 7. Sacrificial writing into functional tissue. (a) A schematic illustration of the printing step. (b) Sequential images showing the fabrication of a perfusable tissue with vascular channels
by extrusion-based printingwithin the tissuematrix connected to inlet and outlet tubes. Scale bar, 10mm. (c) 3Dmodel of a normal humanheart used as a template for the printing (left);
different view of a 1:2 scale polydimethylsiloxane cardiac tissue with septal branches fabricated by extrusion-based printing. Scale bar, 5 mm (right). (images adapted from ref. [139]
Copyright © 2019 American Association for the Advancement of Science)
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diagnostics and therapeutics. In order to fabricate complex 3D vascular
networks which better mimic the native tissue, Grigoryan et al. [154]
used SLA to create a range of intravascular andmulti-vascular networks
within biocompatible hydrogels as shown in Fig. 10(e-h). After success-
fully creating the entangled perfusable networks in PEGDA hydrogel
(Fig. 10(e)), the authors extended the work to create a lung mimetic
unit which comprised an inlet and outlet vascularized network and air
sac as shown in Fig. 10(f). The perfusion test demonstrated that the
printed vascularized hydrogel (PEGDA) could withstand more than
10,000 ventilation cycles over 6 hours during red blood cells (RBC) per-
fusion while switching the inflow gas between humidified oxygen and
humidified nitrogen. With the goal of fabricating structurally complex
and functional tissues, a multi-material liver tissue was created by
seeding the vascularized hydrogel carriers containing hepatocyte aggre-
gateswith ECs as shown in Fig. 10(g, h). The in vivo biocompatibility test
demonstrated the surviving functional hepatocytes, confirming the bio-
compatibility of the printed vascularized tissue. This work made the
preclinical studies possible by providing an approach to overcome the
long-standing design hurdle in functional tissue fabrication.
The main advantage of both SLA and CLIP is that they offer highly
scalable 3D bioprinting similar to extrusion-based printing, while not
compromising with the high resolution similar to inkjet printing. The
Fig. 8. Vascular networks fabricated by thermal extrusion bioprinting (FDM). (a) A schematic illustration of the vascularized construct fabricated by FDM. (b) A single carbohydrate-glass
fibre (200 μm in diameter, top) is encapsulated in a fibrin gel. After removing the carbohydrate-glass, an open perfusable channel in the fibrin gel was created. Scale bar, 500μm. (c) A
confocal image of the vascular network embedded with 10T1/2 cells and seeded with endothelial cells after 24 h culture. Scale bar, 1mm. (images adapted from ref. [149] Copyright ©
2012 Macmillan Publishers Limited) (d) A photograph of the FDM printed mold with four curved arms using PVA as sacrificial material and PLA as support material. (e) A photograph
of the PVA mold after removing the PLA support material. Scale bar, 3 mm. (f) A CAD model of the designed sacrificial mold. (g) The visualized motion program of the sacrificial mold.
Scale bars, 6 mm. (h) A schematic show of the fabrication processes of the vascular construct. (i) A photograph of the sacrificial mold cast in a gelatin hydrogel before removing PVA.
(j) A photograph of the vascularized construct after removing PVA. Scale bars, 1.4 cm. (k) A photograph of the cross-section of the vascularized construct, showing the volumetric
distribution and structural stability of the channels. Scale bar, 5 mm. (l) A photograph of vascularized construct after 24 h of direct perfusion. Scale bar, 4.5 mm. (m, n) Live/dead
confocal microscopy images of the cross-section in the centre with the four channels (m) and the inlet of the perfusion (n) of a 1 cm thick vascularized construct after 15 days of cell
culture. Scale bar, 2 mm. (images adapted from ref. [150] Copyright © 2017 Acta Materialia Inc.)
Fig. 9. Schematic illustrations of (a) conventional stereolithography; and (b) Continuous liquid interface production (CLIP).
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main limitation is that they can be used only with photo-curable inks
which normally are not biocompatible and biodegradable.
3.4. Laser-assisted bioprinting
Laser-assisted bioprinting was initially developed for printing of
metals and electronic components. This technology has now been
imported for printing living cells directly from cell culture suspensions
at a specific location with a lowmargin of error of ± 5 μm in resolution
on 2D or 3D substrates [156]. Based on different laser sources and en-
ergy absorbing layers, there are a few variations of laser-assisted
bioprinting including laser guided direct write (LGDW), laser induced
forward transfer (LIFT), absorbing film-assisted laser induced forward
transfer (AFA-LIFT), matrix-assisted pulsed laser evaporation direct
write (MAPLE-DW) and biological laser printing (BioLP). LGDW differs
from the others as it uses weakly focused continuous laser while the
rest four use pulsed laser. The main difference with LIFT is the use of
high-powered pulsed laser and a thin absorbing layer between the
donor slide and the bioinks. AFA-LIFT and BioLP use a thick absorbing
layer that prevents the direct interaction between laser and the bioinks.
MAPLE-DW uses a low-powered pulsed laser at UV or near-UV wave-
length. Fig. 11(a) schematically shows a representative laser-assisted
bioprinting: a pulsed laser beam is guided throughmirrors onto a liquid
film/bioink which is supported on a thin and transparent solid surface,
e.g. quartz. The liquid film/bioink is a suspension of the cells that are
to be deposited on the substrate. The amount of energy required to
Fig. 10. Vascularized constructs fabricated by SLA. (a) Beam-scanning SLA printing of breast cancer bone model. (b) A schematic 3D view of the triculture model. (c) A schematic of the
in vivo invasion of cancer cells into bone and 2D view of the triculture model. (d) Photo images of 3D printed breast cancer model with top view and side view (the thickness of the
model construct is ≈3 mm). (images adapted from ref. [153] Copyright © 2019 Wiley-VCH) (e) Top: A schematic illustration of a designed entangled vessel topology. Bottom: A
photograph of the SLA printed vessels in hydrogel (20 wt% PEGDA). Scale bar, 3 mm. (f) A photograph of the SLA printed vasculature during perfusion while the air sac was ventilated
with oxygen. Scale bar, 1mm. (g) Vascularized hepatic hydrogel carriers were created by seeding HUVECs in the vascular network after printing. (h) Confocal microscopy observations
show that hydrogel anchors physically entrap fibrin gel containing the hepatocyte aggregates. Scale bar, 1 mm. (images adapted from ref. [154] Copyright © 2019 American Association
for the Advancement of Science)
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generate the laser pulses depends on the laser wavelength, beam thick-
ness and the characteristics and thickness of the liquid film. When the
laser is fired, its energy is absorbed by the liquid film leading to the for-
mation of a tiny vapour bubble. The sudden expansion of the vapour
bubble causes a tiny volume of the liquid to leave the film surface and
fall on the receiver substrate to form transferred material. The volume
of the deposited liquid depends on the laser energy and the liquid.
The laser is guided and fired according to a pre-determined pattern
leading to patterned cell-laden material on the receiver substrate
[157]. Cell viability after laser-assisted bioprinting is affected by three
main parameters, i.e. laser pulse energy, liquid film thickness and vis-
cosity. Catros et al. [158] investigated a range of these three parameters
found that the cell viability was enhanced by increasing bioink viscosity
and film thickness, whilst increasing the laser energy has a negative ef-
fect on the viability of the printed cells.
Although laser-assisted bioprinting offers high printing resolution
and is free from nozzle clogging, it is generally limited to fabricate 2D
patterns due to its intrinsic printing mechanism. Photonic cell damage,
cytotoxicity induced by using metal energy absorbing layer in LIFT and
AFA-LIFT and limited scalability are the main disadvantages of using
this method [21,160]. However, there is increased interest in using
laser-assisted bioprinting to fabricate 3D vascular constructs/hollow
channels for biomedical applications on account of its nozzle-free char-
acteristic and precise deposition ofmaterials [159,161].Moreover, it can
use biomaterials with high viscosities as printing inks which cannot be
used by other techniques mentioned above. Xiong et al. [159] success-
fully fabricated straight and Y-shaped hollow channels using cell-
laden alginate by laser-assisted bioprinting as shown in Fig. 11(b). No
support structure was required for the printing of the branched
Y-shaped tube, demonstrating the feasibility of this technique when
applied to fabricate overhanging structures. The cell viabilities of the
Y-shaped constructs immediately after printing and after 24 h incuba-
tion were 68.1% and 70.8%, respectively, with both being higher than
that of the straight ones. This was attributed to the low landing force
for printing overhang structures, hence resulting in a relatively higher
cell viability.
4. Challenges and future prospects
In vitro vascularization in a tissue-engineered construct is of great
importance for the supply of oxygen and nutrients and excretion
of wastes after implantation in vivo. Especially for tissues with high
level of oxygen consumption rate, suitable vascularization is essential
to the final success of the implantation. Although current 3D
bioprinting technologies have made a remarkable breakthrough in
fabrication of vascular networks, there is still a big gap between
perfusable tubular structures and vasculature. As blood vessels have
layered structures with specific cells and proteins, the first challenge
is to biologically mimic the layered structures of vessels to enable
proper functions. Another vital challenge of 3D bioprinting of
vascularized tissues lies in the accurate production of the complex hi-
erarchical vascular networks which match the host tissues and the
precise positioning of biomaterials, ECs, vascular SMCs and growth
factors to improve vasculature. Current techniques have limitations
in printing vessels frommicrometre-scale to millimetre-scale in a sin-
gle printing process. Furthermore, printing micrometre-scale func-
tional capillaries, which have the equivalent importance to larger
sized vessels for functional vascularized tissues, is yet to be achieved.
One promising approach is to formulate bioinks with vascularization
bioactives which can facilitate angiogenesis to form capillaries. This
will require a good understanding of embryonic development,
mechanobiology, cell-cell/cell-material interactions and biological re-
sponses of ECs to stimuli, such as perfusate flow and hydrostatic pres-
sure. Biomaterials also need to be further formulated to be more
supportive for cell growth with suitable mechanical properties,
while maintaining good tissue structures without collapse in perfu-
sion environment. Another aspect to be improved is the compatibility
of biomaterials with current printing techniques in terms of printabil-
ity, which determines the shape fidelity of printed structures.
Technologically, further effortswill bemade to print awider range of
materials including matrix materials, cells and growth factors in accu-
rate positions simultaneously with high resolution and printing speed.
Multi-nozzle systems of various sizes, integrated into a bioprinter and
independently dispensing multiple biomaterials, may be a promising
approach to print highly scalable multi-material constructs at a high
speed. Additionally, integration of different printing techniques can be
a promising avenue to overcome current technical bottlenecks of 3D
bioprinting. For instance, extrusion-based bioprinting, which suffers
from low resolution while possessing high printing speed, can be com-
bined with high resolution printing techniques, such as inkjet printing
or laser-assisted printing, to fabricate large volumetric tissues with
multi-scaled vascular networks.
In addition to fabricating vascularized tissues in vitro, direct printing
of tissue-engineered constructs in vivowould be highly expected as the
transplantation associated issueswould be eliminated. By incorporating
patients’ anatomical clinical images, highly customized tissue co-
nstructs can be precisely printed in vivo during surgery, which will
drastically reduce the treatment procedures of the conventional
transplantation strategy.
Furthermore, 4D bioprinting has attracted increasing attention, and
is believed to be the next generation of biofabrication technique. As
4D bioprinting is capable of fabricating dynamic 3D biological con-
structs that can be stimulated to change behaviours by using stimuli-
responsive materials [162], therefore, the smart bioinks including ECs,
growth factors can be dynamically controlled to biomimic the natural
vasculature development via 4D printing.
Fig. 11. (a) A schematic illustration of laser-assisted bioprinting process. (b) Images of the Y-shaped hollow channels fabricated by laser-assisted bioprinting using cell-laden hydrogel.
(images adapted from ref. [159] Copyright © 2015 IOP Publishing Ltd.)
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